Being born too soon is now the second-leading killer of children under the age of five, worldwide. The World Health Organisation (WHO) is concerned that preterm birth rates are increasing in many countries.
INFANT focuses on how technology and medicine can improve the health outcomes for neonates (infants less than four weeks old). INFANT’s groundbreaking research in this field meets the need for the accurate identification and reduction of severe neonatal complications.
The PiNPoINT study will develop a nutritional management strategy for very low birth weight, preterm infants.
BabyLink is focused on developing a remote monitoring solution for newborn brain monitoring.
The BABYSAFE study is developing non-invasive technology to help assess fetal well-being.
BEYOND BiHiVE is the next stage of the BiHiVE project, which investigates blood biomarkers.
HiP is Management of Hypotension In the Preterm Infant.
The NESTED study is developing methods of detecting seizures in premature babies.
The ANSeR study is testing a computer algorithm that can detect seizures in babies.
What to expect in the NICU
NeoView focuses on virtual visitation in the NICU.
The NEUROPROBE study will develop an innovative method of continuously analysing changes in preterm EEG, NIRS and blood pressure data.
A smart brain monitoring system for newborns to detect the severity of brain injury.
The CATePILLaR Study is evaluating the impact of COVID-19 restrictions on mother & baby’s health and wellbeing.